CLYDE GREEN: Open Payments
NPI 1417178187 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 78 payments from 24 companies in 2025. Trend: 2023 $1,811 · 2024 $1,406 · 2025 $1,826
Food & beverage: $1,715Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $255 |
| Teva Pharmaceuticals USA, Inc. | 7 | $217 |
| Lundbeck LLC | 6 | $147 |
| Otsuka America Pharmaceutical, Inc. | 6 | $142 |
| Sumitomo Pharma America, Inc. | 8 | $140 |
| AstraZeneca Pharmaceuticals LP | 5 | $117 |
| ABBVIE INC. | 4 | $110 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Novo Nordisk Inc | 3 | $74 |
Products named: REXULTI, CAPLYTA, GEMTESA, INGREZZA, TRELEGY ELLIPTA, UZEDY, UBRELVY, FARXIGA.
Industry payments across GA — which companies pay providers there.
